Easy NAPLEX Renal Therapeutics Practice Questions

Mastering renal therapeutics is a cornerstone of success on the pharmacist licensure exam, as kidney function influences the dosing and safety of nearly every medication class. These Easy NAPLEX Renal Therapeutics Practice Questions are designed to help you build a solid foundation in calculating creatinine clearance, managing electrolyte imbalances, and adjusting drug regimens for patients with chronic kidney disease (CKD). By understanding how the National Kidney Foundation classifies renal stages, you can ensure patient safety and optimize therapeutic outcomes.

Concept Explanation

Renal therapeutics involves the clinical management of patients with impaired kidney function, focusing on drug dose adjustments, electrolyte homeostasis, and the prevention of further renal injury. The kidneys are responsible for filtering waste products, maintaining fluid balance, and regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS). When kidney function declines, as measured by the Glomerular Filtration Rate (GFR) or estimated Creatinine Clearance (CrCl), drugs that are primarily eliminated by the kidneys can accumulate to toxic levels. This requires pharmacists to apply the Cockcroft-Gault equation to determine the appropriate dose for a patient's level of renal impairment. Beyond dosing, renal therapeutics covers the management of complications such as hyperkalemia, hyperphosphatemia, and anemia of chronic kidney disease. For those looking to broaden their clinical knowledge, reviewing our NAPLEX Prep hub provides a structured approach to these complex topics.

Solved Examples

1. Calculating Creatinine Clearance: A 65-year-old male weighs 80 kg and is 5'10" tall. His serum creatinine (SCr) is 1.4 mg/dL. Calculate his CrCl using the Cockcroft-Gault equation.
   1. First, determine the Ideal Body Weight (IBW): $$\text{IBW} = 50 \text{ kg} + 2.3 \times ( \text{inches over 5 feet})$$ $$\text{IBW} = 50 + 2.3 \times (10) = 73 \text{ kg}$$
   2. Since his actual weight (80 kg) is within 120% of his IBW, use IBW for the calculation.
   3. Apply the Cockcroft-Gault formula: $$\text{CrCl} = \frac{(140 - \text{age}) \times \text{weight}}{72 \times \text{SCr}}$$ $$\text{CrCl} = \frac{(140 - 65) \times 73}{72 \times 1.4} = \frac{5475}{100.8} \approx 54.3 \text{ mL/min}$$
2. Managing Hyperphosphatemia: A patient with Stage 5 CKD has a serum phosphorus level of 6.2 mg/dL. Which medication is a first-line non-calcium-based phosphate binder?
   1. Identify the goal: Lower phosphorus without increasing calcium levels.
   2. Evaluate options: Calcium carbonate and calcium acetate are effective but can cause hypercalcemia.
   3. Select the non-calcium agent: Sevelamer carbonate (Renvela) is a common choice that binds phosphate in the GI tract without systemic calcium absorption.
3. Dose Adjustment for Antibiotics: A patient with a CrCl of 25 mL/min requires treatment with Levofloxacin for a UTI. The standard dose is 500 mg daily. How should the dose be adjusted?
   1. Consult renal dosing guidelines (e.g., Sanford Guide or Lexicomp).
   2. For Levofloxacin, if CrCl is between 20-49 mL/min, the dose is typically reduced.
   3. The recommended adjustment is an initial 500 mg dose followed by 250 mg every 24 or 48 hours depending on the specific infection type.

Practice Questions

1. A 72-year-old female (weight 55 kg, height 5'2", SCr 1.8 mg/dL) is diagnosed with a pulmonary embolism. What is her estimated CrCl using the Cockcroft-Gault equation? (Round to the nearest whole number).

2. Which of the following medications is most likely to cause hyperkalemia in a patient with reduced renal function?

3. A patient is receiving hemodialysis three times per week. Which of the following medications should be administered after the dialysis session to avoid being filtered out of the blood?

4. Which laboratory value is the most appropriate indicator for initiating erythropoiesis-stimulating agents (ESAs) in a patient with CKD-related anemia?

5. A patient with CKD is prescribed calcium acetate (PhosLo). What is the primary mechanism of action for this medication in renal disease?

6. Which of the following diuretics is generally considered ineffective for fluid management when a patient's CrCl falls below 30 mL/min?

7. A patient presents with a serum potassium of 6.8 mEq/L and EKG changes (peaked T-waves). Which medication should be administered first to stabilize the cardiac membrane?

8. What is the target blood pressure for a patient with CKD and albuminuria ($>300 \text{ mg/day}$) according to the KDIGO guidelines?

9. Which of the following drugs requires a dose reduction when the CrCl is less than 60 mL/min to prevent the risk of lactic acidosis?

10. A patient is taking Sodium Polystyrene Sulfonate (Kayexalate) for mild hyperkalemia. What is the most common side effect associated with this medication?

Answers & Explanations

1. 21 mL/min. First, calculate IBW: $45.5 + 2.3 \times 2 = 50.1 \text{ kg}$. Using the female version of Cockcroft-Gault: $$\text{CrCl} = \frac{(140 - 72) \times 50.1}{72 \times 1.8} \times 0.85 = \frac{3406.8}{129.6} \times 0.85 \approx 22.3 \text{ mL/min}$$. If using actual body weight (55 kg is within 10% of IBW), the result remains in the low 20s.
2. Lisinopril. ACE inhibitors like Lisinopril decrease aldosterone secretion, which leads to potassium retention. This is a common topic in Easy NAPLEX Hypertension Medication Practice Questions.
3. Atenolol. Low molecular weight, small volume of distribution, and low protein binding make drugs like Atenolol highly dialyzable. They should be given after dialysis to maintain therapeutic levels.
4. Hemoglobin (Hgb) < 10 g/dL. ESAs are typically initiated when Hgb is less than 10 g/dL to avoid the need for blood transfusions, though they are stopped or reduced as Hgb approaches 11 g/dL to minimize stroke risk.
5. Phosphate binding in the gut. Calcium acetate binds to dietary phosphate in the small intestine to form insoluble calcium phosphate, which is then excreted in the feces.
6. Hydrochlorothiazide (HCTZ). Thiazide diuretics lose their efficacy as the CrCl drops below 30 mL/min; loop diuretics (like furosemide) are preferred in advanced CKD.
7. Calcium Gluconate. While it does not lower potassium levels, IV calcium gluconate is the first-line treatment to stabilize the myocardium and prevent arrhythmias in severe hyperkalemia.
8. < 130/80 mmHg. Aggressive blood pressure control is recommended in patients with significant albuminuria to slow the progression of kidney disease. You can find more details on renal-protective agents in our NAPLEX Therapeutics Practice Questions with Answers.
9. Metformin. Metformin is contraindicated or requires careful monitoring/dose reduction in renal impairment (specifically GFR < 30-45 mL/min) due to the risk of metformin-associated lactic acidosis (MALA). This is also covered in Easy NAPLEX Diabetes Medication Practice Questions.
10. Constipation. Sodium Polystyrene Sulfonate is a cation exchange resin that can cause significant GI upset, primarily constipation. It is often administered with a laxative (like sorbitol) to prevent fecal impaction.

1. Which of the following is a common cause of pre-renal acute kidney injury (AKI)?

• ADehydration
• BNephrolithiasis
• CAminoglycoside toxicity
• DProstatic hypertrophy

Frequently Asked Questions

What is the difference between CrCl and GFR?

Creatinine Clearance (CrCl) is an estimate of the rate at which the kidneys clear creatinine from the blood, usually calculated using the Cockcroft-Gault equation for drug dosing. Glomerular Filtration Rate (GFR) is a more accurate measure of actual kidney function used for staging CKD, often calculated via the CKD-EPI or MDRD equations.

Why is the Cockcroft-Gault equation still used for drug dosing?

Most historical pharmacokinetic studies and FDA-approved drug labels were developed using the Cockcroft-Gault equation. While GFR equations are more accurate for staging disease, pharmacists use CrCl to adhere to the manufacturer's validated dosing recommendations.

How do ACE inhibitors protect the kidneys if they can also cause AKI?

ACE inhibitors reduce intraglomerular pressure by dilating the efferent arteriole, which provides long-term protection against protein leakage and scarring. However, this same mechanism can cause a transient, acceptable rise in serum creatinine (up to 30%) or lead to AKI in patients with bilateral renal artery stenosis.

What is the role of Cinacalcet in renal therapeutics?

Cinacalcet is a calcimimetic that increases the sensitivity of calcium-sensing receptors on the parathyroid gland. This leads to a decrease in Parathyroid Hormone (PTH) levels without increasing serum calcium or phosphorus, making it useful for secondary hyperparathyroidism.

When should a pharmacist recommend a dose adjustment for renal function?

Dose adjustments should be considered whenever a patient's calculated CrCl falls below the thresholds specified in the drug's package insert, typically starting at 60 mL/min or 30 mL/min. Utilizing tools like the AI Question Generator can help you practice these specific clinical scenarios.